Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
309 Leser
Artikel bewerten:
(1)

The Leadership Development Group Welcomes Rosemary Bloser As Vice President, Client Solutions

NEW YORK, NY / ACCESSWIRE / April 15, 2021 / The Leadership Development Group, Inc (TLD Group), a global leadership and team development firm, is delighted to welcome Rosemary Mesisca Bloser, MBA as Vice President, Client Solutions. Rosemary, who was previously Managing Partner at Enterprise Learning Solutions (ELS), and Practice Leader, Healthcare and Life Sciences, at the Aresty Institute of Executive Education, the Wharton School, University of Pennsylvania, is a strategic learning and development professional with deep experience in complex problem solving, building relationships, and designing and delivering learning solutions.

"As we expand our reach across the various sectors of the health ecosystem, we are excited to welcome Rosemary to the team. We will draw from Rosemary's experience and healthcare background in new business development, client relationship management, and clinical and research administration to enable TLD Group to continue to provide an unparalleled customer experience for our clients," said Tracy Duberman, PhD, President and CEO of TLD Group.

At ELS, Rosemary assessed industry trends and linked cutting edge research and faculty thought leadership to help develop new, practical content. Prior to ELS, she was responsible for client relationships, team leadership, and design of custom executive development programs at the Wharton School. Formerly, Rosemary was Managing Director for Health Care Management Executive Education at Penn's Leonard Davis Institute of Health Economics (LDI), spent a decade in clinical and research administration with the University of Pennsylvania Health System as the Clinical Department Administrator for General Internal Medicine and Sidney Kimmel Medical College at Thomas Jefferson University as the Director of Financial Operations for the Department of Medicine.

Rosemary's client list includes Association of American Medical Colleges, Children's Hospital of Philadelphia, GlaxoSmithKline, Novartis, Temple University Health System, Trinity Health, and the University of Pennsylvania Health System (Penn Medicine). Rosemary earned her MBA (concentration Information Systems) from Rutgers University and holds a BS in Business Administration from the University of Delaware. She lives in Wilmington, Delaware with her husband and three children.

"My global health care and academic experience coupled with my leadership development experience makes TLD Group a terrific home for me," said Rosemary Bloser. "I look forward to working with TLD Group's world-class faculty and contributing to TLD Group's thought leadership."

The Leadership Development Group (TLD Group) is a full service health ecosystem talent development firm offering customized solutions to help leaders and teams execute strategy through a combination of innovative solutions including Executive Coaching, Team Development Consulting, Leadership Academies and Physician Leadership Training. TLD Group also offers several featured offerings including Virtual Leadership Development, COVID-19 Leadership Support, and Equity, Diversity & Inclusion Programs. For more information on developing customized leadership programs, visit https://www.tldgroupinc.com/.

For further information, contact:

Amy Riemer, Media Relations
978-475-4441 (office) or 978-502-4895 (cell)
amy@riemercommunications.com

SOURCE: The Leadership Development Group



View source version on accesswire.com:
https://www.accesswire.com/640393/The-Leadership-Development-Group-Welcomes-Rosemary-Bloser-As-Vice-President-Client-Solutions

© 2021 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.